Contineum Therapeutics, Inc.
CTNM
$11.01
$0.575.46%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 4.43M | 4.32M | 4.40M | 4.54M | 3.47M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.93M | 17.90M | 18.11M | 17.05M | 12.97M |
| Operating Income | -14.93M | -17.90M | -18.11M | -17.05M | -12.97M |
| Income Before Tax | -12.79M | -16.04M | -15.99M | -14.57M | -10.27M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -12.79M | -16.04M | -15.99M | -14.57M | -10.27M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -12.79M | -16.04M | -15.99M | -14.57M | -10.27M |
| EBIT | -14.93M | -17.90M | -18.11M | -17.05M | -12.97M |
| EBITDA | -14.85M | -17.82M | -18.03M | -16.97M | -12.91M |
| EPS Basic | -0.46 | -0.62 | -0.62 | -0.56 | -0.40 |
| Normalized Basic EPS | -0.28 | -0.39 | -0.39 | -0.35 | -0.25 |
| EPS Diluted | -0.46 | -0.62 | -0.62 | -0.56 | -0.40 |
| Normalized Diluted EPS | -0.28 | -0.39 | -0.39 | -0.35 | -0.25 |
| Average Basic Shares Outstanding | 28.12M | 25.90M | 25.87M | 25.82M | 25.73M |
| Average Diluted Shares Outstanding | 28.12M | 25.90M | 25.87M | 25.82M | 25.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |